Efficacy of Remdesivir in COVID-19
- PMID: 32821934
- DOI: 10.1001/jama.2020.16337
Efficacy of Remdesivir in COVID-19
Comment on
-
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
Similar articles
-
[Remdesivir for patients with COVID-19].Internist (Berl). 2020 Aug;61(8):869-872. doi: 10.1007/s00108-020-00836-7. Internist (Berl). 2020. PMID: 32572516 Free PMC article. German. No abstract available.
-
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6. Int J Antimicrob Agents. 2020. PMID: 32147516 Free PMC article. No abstract available.
-
Pulmonary administration of remdesivir in the treatment of COVID-19.AAPS J. 2020 Sep 17;22(6):121. doi: 10.1208/s12248-020-00506-4. AAPS J. 2020. PMID: 32944838 Free PMC article. No abstract available.
-
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217. J R Coll Physicians Edinb. 2020. PMID: 32568289 Review. No abstract available.
-
A Review of Remdesivir for COVID-19: Data to Date.Cardiol Rev. 2020 Nov/Dec;28(6):332-334. doi: 10.1097/CRD.0000000000000337. Cardiol Rev. 2020. PMID: 32773440 Review.
Cited by
-
Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2.ACS Omega. 2024 Feb 28;9(10):11418-11430. doi: 10.1021/acsomega.3c07845. eCollection 2024 Mar 12. ACS Omega. 2024. PMID: 38496952 Free PMC article.
-
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.ACS Pharmacol Transl Sci. 2024 Jan 19;7(2):493-514. doi: 10.1021/acsptsci.3c00313. eCollection 2024 Feb 9. ACS Pharmacol Transl Sci. 2024. PMID: 38357286
-
Multi-omics for COVID-19: driving development of therapeutics and vaccines.Natl Sci Rev. 2023 May 30;10(9):nwad161. doi: 10.1093/nsr/nwad161. eCollection 2023 Sep. Natl Sci Rev. 2023. PMID: 37936830 Free PMC article. Review.
-
Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models.BMC Chem. 2023 Jul 27;17(1):89. doi: 10.1186/s13065-023-01001-5. BMC Chem. 2023. PMID: 37501208 Free PMC article.
-
Inspiratory Muscle Training While Hospitalized With Acute COVID-19 Respiratory Failure: A Randomized Controlled Trial.J Acute Care Phys Ther. 2023 Jul;14(3):134-142. doi: 10.1097/JAT.0000000000000217. Epub 2023 May 1. J Acute Care Phys Ther. 2023. PMID: 37389410 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources